The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARCELLX INC | COM | 03940C100 | 1,768,491 | 21,177 | SH | SOLE | 21,177 | 0 | 0 | |||
| Arcus Biosciences, Inc | COM | 03969F109 | 13,299,089 | 869,790 | SH | SOLE | 869,790 | 0 | 0 | |||
| AtriCure Inc. | COM | 04963C209 | 751,388 | 26,797 | SH | SOLE | 26,797 | 0 | 0 | |||
| Aura Biosciences, Inc. | COM | 05153U107 | 4,593,595 | 515,555 | SH | SOLE | 515,555 | 0 | 0 | |||
| BeyondSpring Inc. | SHS | G10830100 | 11,354,147 | 4,958,143 | SH | SOLE | 4,958,143 | 0 | 0 | |||
| CG ONCOLOGY INC | COM | 156944100 | 206,715,501 | 5,478,810 | SH | SOLE | 5,478,810 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 8,071,654 | 157,958 | SH | SOLE | 157,958 | 0 | 0 | |||
| CYTOKINETICS INC | COM | 23282W605 | 4,965,470 | 94,043 | SH | SOLE | 94,043 | 0 | 0 | |||
| Equillium Inc. | COM | 29446K106 | 3,700,161 | 4,447,308 | SH | SOLE | 4,447,308 | 0 | 0 | |||
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 4,300,596 | 397,835 | SH | SOLE | 397,835 | 0 | 0 | |||
| GeneDx Holdings Corp. | COM CL A | 81663L200 | 4,396,950 | 103,604 | SH | SOLE | 103,604 | 0 | 0 | |||
| GRAIL INC | COM | 384747101 | 133,252 | 9,684 | SH | SOLE | 9,684 | 0 | 0 | |||
| Illumnia, Inc. | COM | 452327109 | 12,358,565 | 94,767 | SH | SOLE | 94,767 | 0 | 0 | |||
| KRYSTAL BIOTECH INC | COM | 501147102 | 13,064,657 | 71,772 | SH | SOLE | 71,772 | 0 | 0 | |||
| LEGEND BIOTECH CORP-ADR | ADR | 52490G102 | 5,290,031 | 108,558 | SH | SOLE | 108,558 | 0 | 0 | |||
| LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 1,878,146 | 56,350 | SH | SOLE | 56,350 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | COM | G4444C102 | 8,399,972 | 166,600 | SH | SOLE | 166,600 | 0 | 0 | |||
| MERUS NV | COM | N5749R100 | 9,447,336 | 189,098 | SH | SOLE | 189,098 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA CO NV | COM | N62509109 | 9,794,000 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | |||
| Nuvation Bio Inc. | COM | 67080N101 | 59,435,665 | 25,954,439 | SH | SOLE | 25,954,439 | 0 | 0 | |||
| Nuvation Bio Inc. | WARRANTS | 67080N119 | 63,249 | 646,057 | SH | SOLE | 0 | 0 | 0 | |||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 22,600,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | |||
| Pyxis Oncology, Inc (formerly Apexigen) | COM | 747324101 | 1,199,393 | 326,810 | SH | SOLE | 326,810 | 0 | 0 | |||
| REVOLUTION MEDICINES INC(NSM) | COM | 76155X100 | 90,700 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | |||
| VERA THERAPEUTICS INC | COM | 92337R101 | 3,083,701 | 69,767 | SH | SOLE | 69,767 | 0 | 0 | |||
| Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 11,437,789 | 3,108,095 | SH | SOLE | 3,108,095 | 0 | 0 | |||